The Economist Intelligence Unit expands healthcare research capabilities
London, UK: The Economist Intelligence Unit (EIU) announces today the acquisition of Bazian, a leading London-based healthcare information business. Bazian specialises in the analysis and supply of clinical evidence on health services, treatment and health technologies that enable decision makers to assess clinical effectiveness and value for money. The acquisition of Bazian supports The Economist Intelligence Unit’s strategy to expand its offering in the healthcare information business and complements the acquisition of Clearstate in Singapore made in April 2012.
“This acquisition enhances the EIU’s reach and offering in a key sector, Bazian is a growing business with a strong reputation for quality and independence in the UK healthcare market,” says Chris Stibbs, CFO of The Economist Group and managing director of The Economist Intelligence Unit. “After the strategic acquisitions we’ve made this year our healthcare network is now global allowing us to provide enhanced services to our customers.”
Led by Dr Vivek Muthu, Bazian’s staff of highly qualified and experienced medical, information and research professionals cover a wide remit including drugs, diagnostics, procedures and surgeries, devices, entire services and pathways of care and public health and prevention. The company has a strong customer base covering government agencies, NHS organisations, private health insurers, academic institutions and NGOs.
In the short term The Economist Intelligence Unit will support the development of Bazian in its current market with a view to it being a key component in the development of a global health information franchise. Combining its healthcare knowledge and research skills with the market analysis and advisory capabilities supplied by Clearstate and The Economist Intelligence Unit’s healthcare industry knowledge and global sales reach, will provide a powerful base for delivering this vision.
(February 19th 2013)